Commentary: Omalizumab therapy for bullous pemphigoid by KK Yu, AB Crew, KAN Messingham, JA Fairley, DT Woodley. J Am Acad Dermatol 2014 Jun 20. pii: S0190-9622(14)01410-8. doi: 10.1016/j.jaad.2014.04.053. [Epub ahead of print]

Dermatol Ther. 2015 Jan-Feb;28(1):3. doi: 10.1111/dth.12175. Epub 2014 Oct 6.

Author

Affiliation

¹ Department of Dermatology, University of Texas Southwestern Medical Center in Dallas, Dallas, Texas, USA.

PMID: 25286315
DOI: 10.1111/dth.12175

No abstract available

Publication types

Comment

MeSH terms

Anti-Allergic Agents / therapeutic use*
Antibodies, Anti-Idiotypic / therapeutic use*
Antibodies, Monoclonal, Humanized / therapeutic use*
Female
Humans
Pemphigoid, Bullous / drug therapy*

Substances

Anti-Allergic Agents
Antibodies, Anti-Idiotypic
Antibodies, Monoclonal, Humanized